此页面是自动翻译的,不保证翻译的准确性。请参阅 英文版 对于源文本。

近端与远端上臀皮神经阻滞治疗卡压性神经病

2026年11月10日 更新者:Gaziosmanpasa Research and Education Hospital

Proximal Versus Distal Superior Cluneal Nerve Block in Superior Cluneal Nerve Entrapment: A Prospective, Single-Blind Trial

Superior cluneal nerve (SCN) entrapment is an underdiagnosed cause of chronic low back and gluteal pain. Although diagnostic nerve block is considered the gold standard for confirming SCN entrapment, there is no consensus regarding the optimal injection approach. This prospective observational study aims to compare the clinical effectiveness of proximal and distal ultrasound-guided SCN block techniques in patients diagnosed with SCN entrapment. Pain intensity and functional outcomes will be evaluated over the follow-up period to assess differences between the two approaches.

研究概览

详细说明

The primary objective of this study is to compare the effects of two different ultrasound-guided injection techniques on pain intensity, functional status, neuropathic pain components, and quality of life in patients with suspected superior cluneal nerve (SCN) entrapment. Pain severity will be assessed using the Visual Analog Scale (VAS), functional status using the Oswestry Disability Index (ODI), neuropathic pain components using the Leeds Assessment of Neuropathic Symptoms and Signs (LANSS), and quality of life using the Short Form-12 (SF-12). The study aims to determine which injection technique provides superior clinical outcomes.

The secondary objective is to evaluate lumbosacral angle, lumbar lordosis angle, pelvic tilt, sacral tilt, and the presence of scoliosis, and to investigate the relationship between these postural and radiological parameters, SCN entrapment, and treatment response.

Through this study, ultrasound-guided injection techniques used in the diagnosis and treatment of SCN entrapment will be comparatively evaluated, addressing an important gap in the current literature and providing high-level scientific evidence to guide clinicians in the management of chronic low back and gluteal pain.

This study is designed as a prospective, assessor-blinded observational study comparing two different ultrasound-guided injection techniques in patients with superior cluneal nerve entrapment confirmed by diagnostic nerve block. The study population will consist of patients presenting to the Algology Outpatient Clinic of Health Sciences University Gaziosmanpaşa Physical Medicine and Rehabilitation Training and Research Hospital during the study period, who meet the inclusion and exclusion criteria, have chronic low back and/or gluteal pain, are suspected of having SCN entrapment based on clinical examination, have not benefited from conservative treatment, and voluntarily agree to participate in the study.

Based on a power analysis with 95% power, a total of 54 patients are planned to be included in the study, with 27 patients allocated to each group.

研究类型

观察性的

注册 (实际的)

59

联系人和位置

本节提供了进行研究的人员的详细联系信息,以及有关进行该研究的地点的信息。

学习地点

      • Istanbul、土耳其(türkiye)、34255
        • Health Sciences University Gaziosmanpaşa Physical Medicine and Rehabilitation Training and Research Hospita

参与标准

研究人员寻找符合特定描述的人,称为资格标准。这些标准的一些例子是一个人的一般健康状况或先前的治疗。

资格标准

适合学习的年龄

18年 至 75年 (成人、年长者)

接受健康志愿者

不

有资格学习的性别

全部

取样方法

非概率样本

研究人群

The study population will consist of adult patients aged 18 to 75 years presenting with chronic low back and/or gluteal pain lasting longer than three months, who are clinically suspected of having superior cluneal nerve entrapment based on physical examination findings. Eligible participants will be those who have not responded to conservative treatment and who attend the Algology Outpatient Clinic during the study period. Only patients with unilateral symptoms who meet all inclusion and exclusion criteria and who provide written informed consent will be included in the study.

描述

Inclusion Criteria:

  • Age between 18 and 75 years
  • Chronic low back and/or gluteal pain lasting longer than 3 months
  • Localized point tenderness and/or paresthesia on palpation over the unilateral posterior iliac crest
  • Clinical suspicion of superior cluneal nerve entrapment based on physical examination
  • Failure to respond to conservative treatment
  • Ability and willingness to provide written informed consent

Exclusion Criteria:

  • Active local or systemic infection
  • Cognitive impairment or psychiatric disorders interfering with study participation
  • History of malignancy or cancer-related pain
  • Uncontrolled diabetes mellitus or severe comorbid conditions adversely affecting general health
  • Pregnancy
  • Known allergy to the medications used in the injection
  • Prominent radicular pain associated with neurological deficit
  • History of interventional procedures applied to the lumbar region within the last 6 months
  • Initiation of another lumbar interventional or medical treatment during the follow-up period
  • Suspected bilateral superior cluneal nerve entrapment
  • Sphincter dysfunction related to neurological disease
  • Bleeding diathesis or coagulation disorders

学习计划

本节提供研究计划的详细信息,包括研究的设计方式和研究的衡量标准。

研究是如何设计的?

设计细节

  • 观测模型:COHORT
  • 时间观点:PROSPECTIVE

队列和干预

团体/队列
干预/治疗
Proximal SCN Injection (Ultrasound-Guided)

Ultrasound-guided proximal interfascial (plane block) approach for suspected superior cluneal nerve entrapment.

Patients randomized to the proximal injection group will undergo ultrasound-guided injection above the iliac crest level. The target will be the plane beneath the posterior layer of the thoracolumbar fascia. Using an in-plane approach, the injectate will be delivered into the interfascial plane. A total injectate volume of 5 cc (2 cc bupivacaine, 2 cc dexamethasone, and 1 cc normal saline) will be administered under ultrasound guidance. Patient positioning and aseptic conditions will be identical to those used in the distal perineural injection group.

Distal SCN Injection (Ultrasound-Guided)

Ultrasound-guided distal perineural approach for suspected superior cluneal nerve entrapment.

The ultrasound probe will be placed over the posterior superior iliac crest to visualize the fibro-osseous tunnel where the superior cluneal nerve passes. Using an in-plane approach, the needle will be advanced toward the target area, and the injection will be administered at the fascial exit point of the nerve. A total injectate volume of 5 cc (2 cc bupivacaine, 2 cc dexamethasone, and 1 cc normal saline) will be administered. All procedures will be performed in the prone position under standard aseptic conditions.

研究衡量的是什么?

主要结果指标

结果测量
措施说明
大体时间
Visual Analog Scale (VAS)
大体时间:Baseline, 1 month, and 3 months

Primary Outcome Measure Visual Analog Scale for Pain (VAS): Change in pain intensity assessed using the Visual Analog Scale (VAS).The VAS is a 10-cm horizontal scale ranging from 0 (no pain) to 10 (worst imaginable pain).Higher scores indicate greater pain intensity, and a reduction in VAS score represents clinical improvement.

Baseline, 1 month, and 3 months

次要结果测量

结果测量
措施说明
大体时间
Oswestry Disability Index (ODI)
大体时间:Baseline, 1 month, and 3 months

Oswestry Disability Index (ODI): Change in disability related to low back pain assessed using the Oswestry Disability Index (ODI).The validated and reliability-tested Turkish version of the ODI will be used in this study.The ODI consists of 10 items, each scored from 0 to 5, yielding a maximum total raw score of 50.The total score is converted to a percentage using the following formula:ODI percentage = (Total score / 50) × 100

Higher percentage scores indicate greater disability. Disability levels are interpreted as follows:

  • 0-20%: Minimal disability
  • 21-40%: Moderate disability
  • 41-60%: Severe disability
  • 61-80%: Crippling disability
  • 81-100%: Bed-bound or exaggerated symptoms

A decrease in ODI percentage score indicates improvement in functional status.

Baseline, 1 month, and 3 months
Leeds Assessment of Neuropathic Symptoms and Signs (LANSS)
大体时间:Baseline, 1 month, and 3 months

Assessment of neuropathic pain features using the Leeds Assessment of Neuropathic Symptoms and Signs (LANSS) questionnaire.The LANSS scale consists of 7 items with a total score ranging from 0 to 24.A score of ≥12 indicates the presence of neuropathic pain mechanisms.Higher scores reflect greater neuropathic pain components.

Baseline, 1 month, and 3 months
Short Form-12 Health Survey (SF-12)
大体时间:Baseline, 1 month, and 3 months

Health-related quality of life assessed using the Short Form-12 Health Survey (SF-12).The SF-12 generates two composite scores:

  • Physical Component Summary (PCS)
  • Mental Component Summary (MCS) Both PCS and MCS scores are calculated according to standard scoring algorithms.Higher scores indicate better physical and mental health-related quality of life, respectively.In this study, PCS and MCS scores will be analyzed separately to evaluate physical and mental aspects of quality of life.
Baseline, 1 month, and 3 months
Baseline Postural and Radiological Characteristics in Patients with Superior Cluneal Nerve Entrapment
大体时间:Baseline (pre-intervention)

Baseline postural and radiological characteristics will be assessed prior to intervention in patients with superior cluneal nerve entrapment. Previously obtained standing lateral lumbosacral and pelvic radiographs will be used. Lumbar lordosis, sacral slope, lumbosacral angle, and pelvic tilt will be measured as radiographic angles in degrees on standing lateral images and categorized as decreased/normal/increased (lumbar lordosis, sacral slope, lumbosacral angle) or anterior/normal/posterior (pelvic tilt). Scoliosis will be evaluated based on physical examination and review of existing radiographs and MRI scans; when clinically indicated, standing scoliosis radiographs will be obtained. Scoliosis will be assessed using the Cobb method and recorded as present or absent. These findings will be descriptively reported.

Baseline (pre-intervention)

合作者和调查者

在这里您可以找到参与这项研究的人员和组织。

调查人员

  • 学习椅:Tugce Yavuz Mollavelioglu, MD、Gaziosmanapasa Educational and Training Hospital

出版物和有用的链接

负责输入研究信息的人员自愿提供这些出版物。这些可能与研究有关。

研究记录日期

这些日期跟踪向 ClinicalTrials.gov 提交研究记录和摘要结果的进度。研究记录和报告的结果由国家医学图书馆 (NLM) 审查,以确保它们在发布到公共网站之前符合特定的质量控制标准。

研究主要日期

学习开始 (实际的)

2025年12月12日

初级完成 (实际的)

2026年7月30日

研究完成 (实际的)

2026年7月30日

研究注册日期

首次提交

2026年1月6日

首先提交符合 QC 标准的

2026年1月19日

首次发布 (实际的)

2026年1月28日

研究记录更新

最后更新发布 (实际的)

2026年11月16日

上次提交的符合 QC 标准的更新

2026年11月10日

最后验证

2026年10月1日

更多信息

与本研究相关的术语

计划个人参与者数据 (IPD)

计划共享个人参与者数据 (IPD)?

不

IPD 计划说明

Individual participant data will not be shared due to institutional data protection policies and the absence of participant consent for data sharing beyond the scope of the current study.

药物和器械信息、研究文件

研究美国 FDA 监管的药品

不

研究美国 FDA 监管的设备产品

不

此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.

订阅